These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3322751)

  • 1. Mode of action of nitro-heterocyclic compounds on Escherichia coli.
    Hof H; Chakraborty T; Royer R; Buisson JP
    Drugs Exp Clin Res; 1987; 13(10):635-9. PubMed ID: 3322751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activities of nitrothiazole derivatives.
    Hof H; Zak O; Schweizer E; Denzler A
    J Antimicrob Chemother; 1984 Jul; 14(1):31-9. PubMed ID: 6384174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs.
    Nillius D; Müller J; Müller N
    J Antimicrob Chemother; 2011 May; 66(5):1029-35. PubMed ID: 21393225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-hydroxyarylamine O-acetyltransferase-deficient Escherichia coli strains are resistant to the mutagenicity of nitro compounds.
    Josephy PD; Summerscales J; DeBruin LS; Schlaeger C; Ho J
    Biol Chem; 2002 Jun; 383(6):977-82. PubMed ID: 12222687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of nitro drugs metronidazole and nitazoxanide in Giardia lamblia: characterization of a novel nitroreductase (GlNR2).
    Müller J; Schildknecht P; Müller N
    J Antimicrob Chemother; 2013 Aug; 68(8):1781-9. PubMed ID: 23580565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli.
    Sandegren L; Lindqvist A; Kahlmeter G; Andersson DI
    J Antimicrob Chemother; 2008 Sep; 62(3):495-503. PubMed ID: 18544599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative importance of bacterial and mammalian nitroreductases for niridazole mutagenesis.
    Blumer JL; Friedman A; Meyer LW; Fairchild E; Webster LT; Speck WT
    Cancer Res; 1980 Dec; 40(12):4599-605. PubMed ID: 6893679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitization of bacteria to the action of chemical agents by insertion of 5-bromouracil in DNA. Communication I. Sensitization by 5-bromouracil to the lethal and mutagenic action of 4-nitroquinoline-1-oxide of strains of Escherichia coli with or without dark repair ability.
    Kondrat'ev YuS ; Skavronskaya AG
    Sov Genet; 1974 Jul; 8(7):888-91. PubMed ID: 4608428
    [No Abstract]   [Full Text] [Related]  

  • 9. Steady-state and stopped-flow kinetic studies of three Escherichia coli NfsB mutants with enhanced activity for the prodrug CB1954.
    Jarrom D; Jaberipour M; Guise CP; Daff S; White SA; Searle PF; Hyde EI
    Biochemistry; 2009 Aug; 48(32):7665-72. PubMed ID: 19580253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroaryl phosphoramides as novel prodrugs for E. coli nitroreductase activation in enzyme prodrug therapy.
    Hu L; Yu C; Jiang Y; Han J; Li Z; Browne P; Race PR; Knox RJ; Searle PF; Hyde EI
    J Med Chem; 2003 Nov; 46(23):4818-21. PubMed ID: 14584930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the biological activity of some nitrothiophenes.
    Morley JO; Matthews TP
    Org Biomol Chem; 2006 Jan; 4(2):359-66. PubMed ID: 16391779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic activities of nitrothiazoles against trichomonads.
    Hof H; Müller KM; Schrank W; Schweizer EH; Zak O
    Arzneimittelforschung; 1987 Mar; 37(3):306-9. PubMed ID: 3496102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: a phase I, open-label, noncomparative clinical trial in healthy volunteers.
    Ponte C; Gracia M; Giménez MJ; Aguilar L; Maín CM; Carpintero Y; Huelves L; Carcas A; del Prado G; Soriano F
    Clin Ther; 2005 Jul; 27(7):1043-9. PubMed ID: 16154483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel 5-Nitrofuran-Activating Reductase in Escherichia coli.
    Le VVH; Davies IG; Moon CD; Wheeler D; Biggs PJ; Rakonjac J
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial action of quinolones on Escherichia coli. I. Structure/activity relationship.
    Mahmood F; Mahmood NH; Holms WH
    Zentralbl Bakteriol A; 1980 Mar; 246(3):329-35. PubMed ID: 6999788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of different nitroheterocyclic compounds on aerobic, microaerophilic, and anaerobic bacteria.
    Hof H; Ströder J; Buisson JP; Royer R
    Antimicrob Agents Chemother; 1986 Nov; 30(5):679-83. PubMed ID: 3800344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrazole sulfanilamides: nitroderivatives of 1-phenyl-3-sulfanilamidopyrazole. Note XVI.
    Tironi C; Fruttero R; Garrone A
    Farmaco; 1990 Apr; 45(4):473-8. PubMed ID: 2205221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escherichia coli BTC, a human cytochrome P450 competent tester strain with a high sensitivity towards alkylating agents: involvement of alkyltransferases in the repair of DNA damage induced by aromatic amines.
    Duarte MP; Palma BB; Laires A; Oliveira JS; Rueff J; Kranendonk M
    Mutagenesis; 2005 May; 20(3):199-208. PubMed ID: 15843388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygen-insensitive nitroreductases: analysis of the roles of nfsA and nfsB in development of resistance to 5-nitrofuran derivatives in Escherichia coli.
    Whiteway J; Koziarz P; Veall J; Sandhu N; Kumar P; Hoecher B; Lambert IB
    J Bacteriol; 1998 Nov; 180(21):5529-39. PubMed ID: 9791100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the nitroreductase prodrug-activating system. Crystal structures of complexes with the inhibitor dicoumarol and dinitrobenzamide prodrugs and of the enzyme active form.
    Johansson E; Parkinson GN; Denny WA; Neidle S
    J Med Chem; 2003 Sep; 46(19):4009-20. PubMed ID: 12954054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.